Pharmaceutical Chemistry Journal

Pharmaceutical Chemistry Journal英文簡(jiǎn)介

Pharmaceutical Chemistry Journal is a monthly publication devoted to scientific and technical research on the creation of new drugs and the improvement of manufacturing technology of drugs and intermediates. International contributors cover the entire spectrum of new drug research, including:

methods of synthesis;

results of pharmacological, toxicological, and biochemical studies;

investigation of structure - activity relationships in prediction of new compounds;

methods and technical facilities used; and

problems associated with the development of ecologically safe and economically feasible methods of industrial production.

In addition, analytical reviews of the international literature in the field provide coverage of the most recent developments around the world.

Pharmaceutical Chemistry Journal is a translation of the Russian journal Khimiko-Farmatsevticheskii Zhurnal. The Russian Volume Year is published in English from April.

All articles are peer-reviewed.

Pharmaceutical Chemistry Journal中文簡(jiǎn)介

《Pharmaceutical Chemistry Journal》是一本由SPRINGER出版商出版的專業(yè)醫(yī)學(xué)期刊，該刊創(chuàng)刊于1967年，刊期Monthly，該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄。在中科院最新升級(jí)版分區(qū)表中，該刊分區(qū)信息為大類學(xué)科：醫(yī)學(xué) 4區(qū)，小類學(xué)科：藥物化學(xué) 4區(qū)；藥學(xué) 4區(qū)；在JCR（Journal Citation Reports）分區(qū)等級(jí)為Q4。該刊發(fā)文范圍涵蓋藥物化學(xué)等領(lǐng)域，旨在及時(shí)、準(zhǔn)確、全面地報(bào)道國(guó)內(nèi)外藥物化學(xué)工作者在該領(lǐng)域取得的最新研究成果、工作進(jìn)展及學(xué)術(shù)動(dòng)態(tài)、技術(shù)革新等，促進(jìn)學(xué)術(shù)交流，鼓勵(lì)學(xué)術(shù)創(chuàng)新。2021年影響因子為1.063，平均審稿速度一般,3-8周。

中科院分區(qū)最新升級(jí)版（當(dāng)前數(shù)據(jù)版本：2021年12月最新升級(jí)版）

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)	Top期刊	綜述期刊
醫(yī)學(xué)	4區(qū)	CHEMISTRY, MEDICINAL 藥物化學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	4區(qū) 4區(qū)	否	否

JCR分區(qū)（當(dāng)前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級(jí)	JCR所屬學(xué)科	分區(qū)	影響因子
Q4	PHARMACOLOGY & PHARMACY	Q4	1.063
	CHEMISTRY, MEDICINAL	Q4

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
1.063	26	0.00%	96.17%	未開放	一般,3-8周

IF值(影響因子)趨勢(shì)圖